Perimenopausal DUB. Mary Anne Jamieson, MD Associate Professor, OB/GYN Queen s University Kingston, Ontario

Similar documents
Abnormal Uterine Bleeding: Evaluation of Premenopausal Women. Vanessa Jacoby, MD, MAS Assistant Professor Ob, Gyn, & Reproductive Sciences UCSF

CLEAR COVERAGE HYSTERECTOMY CHECKLISTS

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre

Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.

5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

PALM-COEIN: Your AUB Counseling Guide

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Gynecologic Decision Making Based on Sonographic Findings

Dr Mary Birdsall. Fertility Associates Auckland

Chapter 100 Gynecologic Disorders

Healthcare Education Research

Fibroid mapping. Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital

Menstrual Disorders & Ambulatory Gynaecology

Abnormal Uterine Bleeding

Abnormal uterine bleeding:

Heavy Menstrual Bleeding. Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist

Abnormal Uterine Bleeding Case Studies

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

Palm Beach Obstetrics & Gynecology, PA

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

Topics. Periods Menopause & HRT Contraception Vulva problems

Dysfunctional Uterine Bleeding

Dysfunctional Uterine Bleeding (DUB) OB/GYN Hospital of Fudan University Weiwei Feng, MD,Ph D Tel:

Dysmenorrhea. Erin Eppsteiner, M.D. Department of Ob/Gyn The University of Iowa Roy J & Lucille A Carver College of Medicine

of AUB DISCLOSURES 10/29/2018

reproductive organs. Malignant neoplasms. 4. Inflammatory disorders of female reproductive organs 2 5. Infertility. Family planning.

Index. Note: Page numbers of article titles are in boldface type.

Investigating HMB- an evidence based approach

Elaina Sexton, MD, MSc Obstetrics and Gynecology St. Vincent s Hospital. Objectives

5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe

Overview of Reproductive Endocrinology

Abnormal Uterine Bleeding. Richard Dover Specialist gynaecologist

Patient Health Forms

Freedom of Information

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages

Primary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING

Managing Menstrual Disorders

International Journal of Health Sciences and Research ISSN:

Management of Abnormal Uterine Bleeding. Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology

Infertility for the Primary Care Provider

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

AUB. Postmenopausal. Approximately 1 of every 8 postmenopausal. Rule out endometrial cancer first OBG COVER ARTICLE

Abnormal vaginal bleeding is a common complaint. Abnormal Uterine Bleeding in Reproductive- Aged Women. Case-based review

Aulia Rahman, S. Ked Endang Sri Wahyuni, S. Ked Nova Faradilla, S. Ked

Contraception and gynecological pathologies

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

DIP.G.O. EXAMINATION 2007

Cervical Cancer - Suspected

NICE guideline Published: 14 March 2018 nice.org.uk/guidance/ng88

Hysterectomy : A Clinicopathologic Correlation

Prevention, Diagnosis and Treatment of Gynecologic Cancers

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

MEDICAL POLICY SUBJECT: ENDOMETRIAL ABLATION

Orals,Transdermals, and Other Estrogens in the Perimenopause

Reproductive Health and Pituitary Disease

Question Bank III - BHMS

Objectives. Acknowledgements & Disclosures 5/28/2014. Evaluation of Abnormal Uterine Bleeding: The New Name of the Game

The Centre for Reproductive Medicine HYSTERECTOMY

Perimenopausal Age Group (45-55yrs): For Early Detection And Treatment.

Polycystic Ovary Syndrome (PCOS):

5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle

Endometriosis. *Chocolate cyst in the ovary

Chronic Pelvic Pain. Bridget Kamen, MD Obstetrics and Gynecology, Confluence Health. I have no disclosures

Dysmenorrhoea Gynaecology د.شيماءعبداالميرالجميلي. Aetiology of secondary dysmenorrhea

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)

Endometriosis and Infertility - FAQs

Treatment of Heavy Menstrual Bleeding: Ludkin (Nurse Hysteroscopist, Bradford Royal Infirmary) & M Rogers (Advanced

Gynecologic Considerations in Women with FA

Not all roads point to hysterectomy: treatment options for fibroids

Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives

GLOBAL ENDOMETRIAL ABLATION TECHNOLOGY

If you do not have time for the entire presentation refer to the following table of contents. To navigate through the slides, right click on your

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the

Ardhanu Kusumanto Oktober Contraception methods for gyne cancer survivors

The facts about Endometriosis

Fibroids. Very Common! Benign smooth muscle tumors of the myometrium 20-80% of women develop fibroids by age 50* 151 million women affected**


Management of Uterine Myomas

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?

All about common gynaecological conditions

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Dr Devashana Gupta. Repromed Auckland. 17:30-18:00 Fibroids, Endometriosis and DUB

Role of diagnostic hysteroscopy in evaluation of abnormal uterine bleeding and its histopathological correlation

1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S.

Medical Management of Fibroids Esmya. Dr Paula Briggs Consultant in Sexual and Reproductive Health

Moneli Golara Consultant Obstetrician and Gynaecologist Barnet Hospital Royal Free NHS Trust

Infertility DR. RAHUL BEVARA

ANEMIA AND HEAVY MENSTRUAL BLEEDING

Gayatrri Anipindi *, Vani I. Original Research Article. Abstract

Secondary amenorrhoea Dr.ASMAA AL SANJARY

Protect & Detect: What Women should Know about cancer. The American College of Obstetricians and Gynecologists

Contents: Benign Diseases of the Uterus

University Gynecologic Oncology Associates

Dr. Mojibian. Menopause

Transcription:

Perimenopausal DUB Mary Anne Jamieson, MD Associate Professor, OB/GYN Queen s University Kingston, Ontario

Objectives Clinicians will: Make a confident diagnosis for Perimenopausal DUB (know how/when to exclude other etiologies in that age group) Choose first-line treatment options that are most likely to be satisfactory and effective. Know when reassurance is all that is necessary Confidently decide when to refer to gynecology

No conflict to disclose

Abnormal Vaginal Bleeding Differential Diagnosis HPOO Axis & Miscellaneous Hypothalamic / Central Pituitary Ovarian/Gonadal (Adrenal) Outflow (Uterus, Cervix, Vagina, Vulva) Miscellaneous

AVB Differential Diagnosis HPOO Axis Hypothalamic / Central Extremes of Diet/Stress/Exercise Chronic Illness CNS lesion

AVB Differential Diagnosis HPOO Axis Pituitary Lesion: Prolactinoma, neoplasm Thyroid endocrinopathy

AVB Differential Diagnosis HPOO Axis Ovarian/gonadal (Adrenal) Perimenarchal / Perimenopausal PCOS (*obesity*) Neoplasm (ovary or adrenal) Menopause / POF (POI) CAH/addisons/cushings Meds (dopamine)

AVB Differential Diagnosis Outflow tract Uterus: HPOO Axis Fibroids, polyps, adenomyosis, (*endometriosis*), endometritis, hyperplasia/cancer Cervix Polyps, cervicitis, ectropion, dysplasia / cancer Vagina/Vulva Infection, neoplasm, dermopathy

AVB Differential Diagnosis Miscellaneous Pregnancy Medications: Psychotropic & anticonvulsants Stomach motility agents Anticoagulants Coagulopathy

Abnormal Vaginal Bleeding: HX & PE HPOO AXIS History: What exactly is the menstrual history Is she consistently and regularly ovulatory? Stigmata: ex Extremes diet, Thyroid symptoms, galactorrhea, acne/hirsutism, hot flashes, psychotropic meds Physical Exam: Ht, Wt, BMI Stigmata: ex Disordered eating, periph vision, hyperandrogenism, AN, abdominal mass, V/V/Cx & Bimanual: ex, enlarged uterus, cervix polyp

YOU CONCLUDE: Most Likely Perimenopausal Menometrorragia

Perimenopausal Menometrorrhagia Labs (just to quantify & be confident): CBC, TSH, *?prolactin*,?fsh, Cx swabs, (pap) Consider Endometrial biopsy Endometritis Hyperplasia or cancer Fragment of polyp Pelvic Ultrasound +/- saline-enhancement

When to Biopsy Endometrium IN CONTEXT OF PERIMENOPAUSAL DUB, ALMOST ALWAYS Risk Factors for Endometrial Hyperplasia / Cancer Age >45 Obesity Family History of Endometrial Cancer Family History of Colon Cancer Chronic Anovulation Infertility & Nulliparity

YOU CONCLUDE: Most Likely Perimenopausal Menometrorragia If they are coping you don t HAVE TO Treat

Perimenopausal Menometro: Treatment Options NSAIDS (* only really if predictable &/or painful) Tranexamic Acid: 500-1000 mg Q8h Combined contraceptives (+/- extended cycle) Long-acting progestins (Depo, LIUS) Danazol: start at 200mg po daily GnRH analogue (temporize or preop) Ablation (childbearing complete-not adeno or # fibroids) Embolization (fibroids, childbearing complete) Hysterectomy D&C is NOT Effective as Treatment Myomectomy would very rarely be appropriate in perimenopause unless Hysteroscopic

Treatment Options How do you decide? Is she in need of Contraception? Is there both PAIN & FLOW complaints? Did you find coexisting Intramural fibroids? Is she otherwise symptomatic from perimenopause? (ex hot flushes) Does she have any contraindications to particular modalities? (ex smoker >35 yo) Does she have Health Benefits? Short term disability, Coverage for Meds Is she willing to take a daily pill? How long do you think this problem will last? Is she already skipping periods and convincingly symptomatic

Perimenopausal Menometro: Treatment Options NSAIDS (* only really if predictable &/or painful) Tranexamic Acid: 500-1000 mg Q8h Combined contraceptives (+/- extended cycle) Long-acting progestins (Depo, LIUS) Danazol: start at 200mg po daily GnRH analogue (temporize or preop) Ablation (childbearing complete- not adeno or # fibroids) Embolization (fibroids, childbearing complete) Hysterectomy

A few key reviews Guidelines for the Mgmt of Abnormal Uterine Bleeding. SOGC CPG 106, Aug/01 Gyne & OBs Mgmt of Women with Inherited Bleeding Disorders. SOGC CPG 163, July/05 How Best to Manage DUB. Maness DL, Journal of Family Practice 59(8) Aug 2010. Mgmt of DUB. Casablanca Y, ObGyn Clinics of NA #35 2008. Diagnosis if Abnormal Bleeding. Mohan S. Best Practice & Res Clin OB/GYN 21(6) 2007 SOGC.org has CPGs on Embolization, Mgmt of Fibroids

A few other refs Fraser IS. The promise and reality of the intrauterine route for hormone delivery for prevention & therapy of gynecological disease. Contraception Jun 2007 #75 Buttini MJ. The effect of the levonorgl releasing intrauterine system on endometrial hyperplasia. Aust NZJ of OB/GYN June 2009 #49(3) Mansour D. Modern mgmt of abn uterine bleeding: the LIUS. Best Pract Res Clin OB/GYN Dec 2007 #21(6) Sitruk-Ware R. The LIUS for use in peri- and postmenopausal women. Contraception June 2007 #75. Kaunitz A. Levo Releasing Intrauterine System and Endometrial Ablation in Heavy Menstrual Bleeding. A systematic review and meta-analysis. Obstet Gyne May 2009 #13(5)